Body Surface Area Calculator: 8 Medical Formulas

• Who it helps:
  Clinicians calculating chemotherapy doses (prescribed per m²), nursing and medical students, and health-conscious individuals who need a BSA value for Cardiac Index, GFR normalization, or burn-area assessment.
• What it outputs:
  BSA in m² for the selected formula (or consensus average), a side-by-side comparison of all eight formulas, and a variance indicator showing how much formulas disagree for your inputs.
• What it does NOT do:
  It does not replace clinical judgment for patients at body-weight extremes or those with atypical body proportions. Many chemotherapy protocols cap BSA at 2.0 m² regardless of the calculated value. All calculations run locally; no data is stored.

• Formula selection:
  Choose a specific formula or select Consensus Mode to average all formulas. For general adult use, Mosteller or Du Bois are appropriate. For pediatric patients under 18, use Haycock, which is optimized for children’s body proportions.
• Reading results:
  Average adults are approximately 1.7 m² (women) and 1.9 m² (men). If the variance between formulas exceeds 5%, the patient may have atypical proportions requiring clinical judgment.
• Comparing formulas:
  Review the side-by-side comparison panel to identify outliers. High disagreement between formulas is itself a clinical signal—consider which formula best matches the patient’s population or use consensus averaging for maximum defensibility.

Understanding Each BSA Calculation Method

• Mosteller (1987):
  $$\text{BSA} = \sqrt{\frac{H \times W}{3600}}$$

  H = height (cm), W = weight (kg). Simplest formula; widely used for bedside estimates.

• Du Bois & Du Bois (1916):
  $$\text{BSA} = 0.007184 \times W^{0.425} \times H^{0.725}$$

  Original BSA formula; clinical standard for drug protocols.

• Haycock (1978):
  $$\text{BSA} = 0.024265 \times W^{0.5378} \times H^{0.3964}$$

  Preferred for pediatric patients and neonates.

• Gehan & George (1970):
  $$\text{BSA} = 0.0235 \times W^{0.51456} \times H^{0.42246}$$

  Regression-derived; similar to Du Bois. Referenced in oncology protocols.

• Boyd (1935):
  $$\text{BSA} = 0.03330 \times W^{0.6157 - 0.0188 \log_{10} W} \times H^{0.3}$$

  Logarithmic weight adjustment; may perform better at extreme body weights.

• Fujimoto & Takahira (1968):
  $$\text{BSA} = 0.008883 \times H^{0.663} \times W^{0.444}$$

  Calibrated on Japanese population data.

• Schlich (2010):
  $$\text{Male: } \text{BSA} = 0.000579479 \times H^{1.24} \times W^{0.38}$$

  $$\text{Female: } \text{BSA} = 0.000975482 \times H^{1.08} \times W^{0.46}$$

  Gender-specific; accounts for body composition differences.

How BSA Is Used in Clinical Practice

• Chemotherapy Dosing:
  $$\text{Dose} = \text{BSA} \times \text{Protocol Dose per m}^2$$

  Most cytotoxic drugs dosed in mg/m². Protocols often cap BSA at 2.0 m².

• Cardiac Index:
  $$\text{Cardiac Index} = \frac{\text{Cardiac Output}}{\text{BSA}}$$

  Normal range: 2.5-4.0 L/min/m². Allows comparison across body sizes.

• Glomerular Filtration Rate (GFR):
  $$\text{GFR}_{\text{norm}} = \text{GFR}_{\text{measured}} \times \frac{1.73}{\text{BSA}}$$

  GFR normalized to standard BSA 1.73 m² for cross-patient comparison.

• Burn Assessment:
  The "Rule of Nines" estimates burn area as percentage of BSA. Fluid resuscitation formulas (like Parkland: 4 mL × kg × %BSA burned) use BSA percentage to calculate IV fluid requirements. Accurate BSA estimation is critical, errors lead to inadequate or excessive resuscitation.
• Mechanical Ventilation:
  Tidal volume targets are often set based on ideal body weight or BSA rather than actual weight. This prevents ventilator-induced lung injury in obese patients who would receive excessive volumes based on actual weight alone.

Normal BSA Ranges by Age Group

• Newborns (0.20-0.25 m²):
  Full-term newborns average approximately 0.25 m² BSA at ~3.5 kg weight and ~50 cm length. Their high surface-to-volume ratio means rapid heat loss (requiring incubators) and higher metabolic rate per kg body weight. Drug dosing requires pediatric-specific formulas and extreme care.
• Infants & Toddlers (0.3-0.6 m²):
  BSA increases rapidly during the first years, roughly doubling by age 1-2. A 1-year-old (~10 kg, 75 cm) typically has BSA around 0.45 m². The Haycock formula is strongly preferred for this age group where body proportions differ significantly from adults.
• Children (0.6-1.2 m²):
  School-age children (5-10 years) show BSA ranging from ~0.75 m² (5 years, 18 kg) to ~1.14 m² (10 years, 32 kg). Growth spurts cause BSA to increase faster than weight alone would predict. Pediatric oncology protocols often transition from weight-based to BSA-based dosing in this range.
• Adolescents (1.2-1.8 m²):
  Teenagers approach or reach adult BSA values, with 15-year-olds averaging ~1.60 m² (55 kg, 165 cm). Timing varies with puberty. Gender differences become apparent, males typically achieve higher BSA. Adult formulas become appropriate by late adolescence (16-18 years).
• Adults (1.5-2.2 m²):
  Adult BSA averages 1.7 m² for women (62 kg, 163 cm typical) and 1.9 m² for men (75 kg, 175 cm typical). Large adults may reach 2.2+ m². BSA remains relatively stable throughout adulthood unless weight changes significantly. Elderly patients may show slightly lower BSA due to height loss and sarcopenia.

Choosing the Right Formula for Your Situation

• General Adult Use:
  Mosteller or Du Bois are appropriate for most adult patients (BMI 18-35). They're widely validated, clinically accepted, and produce similar results (typically within 2%). Most drug protocols reference these formulas. Use Mosteller for simplicity; Du Bois when protocol specifically requires it.
• Pediatric Patients:
  Use Haycock formula for all patients under 18, especially infants and neonates. Adult-derived formulas systematically underestimate pediatric BSA due to different body proportions (higher surface-to-volume ratio). Many pediatric protocols specifically mandate Haycock.
• Asian Populations:
  Consider Fujimoto formula for patients of East Asian descent. While not universally validated across all Asian populations, it was specifically calibrated using Japanese data and may provide more accurate estimates than Western-derived formulas.
• Extreme Body Weights:
  For severe obesity (BMI > 40) or severe underweight (BMI < 16), all formulas show increased variance and potential systematic error. Boyd's logarithmic adjustment may perform better at extremes. Consider using consensus averaging AND clinical judgment for these patients.
• Maximum Clinical Confidence:
  Use Consensus Mode (mean of all formulas) when accuracy is critical and no specific formula is mandated. This approach minimizes systematic bias, accounts for population variation, and provides the most statistically defensible estimate. The variance percentage output indicates formula agreement, high variance (>5%) suggests the patient may be atypical.